Cisco
CSCO
Disney
DIS
Adobe
ADBE
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
RENB Renovaro
- 1.005
- -0.185-15.55%
Close Feb 27 16:00 ET
- 0.980
- -0.025-2.49%
Post 20:01 ET
159.51MMarket Cap-1.29P/E (TTM)
1.160High0.968Low2.58MVolume1.050Open1.190Pre Close2.70MTurnover3.35%Turnover RatioLossP/E (Static)158.72MShares3.38052wk High1.94P/B77.56MFloat Cap0.39552wk Low--Dividend TTM77.17MShs Float13.780Historical High--Div YieldTTM16.11%Amplitude0.393Historical Low1.045Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Renovaro Stock Forum
Can Renovaro's AI Biotech Merger Transform Drug Discovery? Major Pharma Already Onboard
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
Wednesday, 26th February at 1:25 pm
Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond
LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug d...
Another new PR
Renovaro Biosciences Buys AI-Driven BioSymetrics
more news just out
Renovaro and Biosymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
👀
No comment yet